Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts - Krishan Kumar; Simon Wigfield; Harriet E. Gee; Cecilia M. Devlin; Dean Singleton; Ji-Liang Li; Francesca Buffa; Melanie Huffman; Anthony L. Sinn; Jayne Silver; Helen Turley; Russell Leek; et al. (Journal of Molecular Medicine, 2013)